Skip to main content
Download PDF
Download ePub

Nonlinear connection between remnant cholesterol and stroke risk: evidence from the China health and retirement longitudinal study

Lipids in Health and Disease volume 22, Article number: 181 (2023) Cite this article

Abstract

Objective

The evidence on the relationship between remnant cholesterol (RC) and stroke remains controversial. Therefore, this study aimed to explore the relationship between RC and stroke risk in a Chinese population of middle-aged and elderly individuals.

Methods

The present study included 10067 Chinese subjects of middle-aged and elderly individuals. The connection between RC and incident stroke was investigated using the multivariate Cox proportional hazards regression model, several sensitivity analyses, generalized additive models, and smoothed curve fitting.

Results

A total of 1180 participants with stroke were recorded during the follow-up period. The multivariate Cox proportional hazards regression model identified a positive connection between RC and stroke risk (hazard ratio (HR) = 1.087, 95% confidence interval (CI): 1.001–1.180). In addition, the current study discovered a nonlinear connection between RC and incident stroke, and the point of inflection for RC was 1.78 mmol/L. The risk of stroke increased by 25.1% with each unit increase in RC level when RC was < 1.78 mmol/L (HR:1.251, 95%CI: 1.089–1.437, P = 0.0015). The results were not affected by sensitivity tests.

Conclusion

The current study showed a positive and nonlinear connection between RC and stroke risk in a middle-aged and elderly Chinese population. These findings provided new information to help researchers better understand the relationship between RC levels and incident stroke.

Introduction

Stroke is the most common cause of disability and death and is a worrisome worldwide health problem [1]. Despite a continuous decline in age-standardized stroke mortality rates, the high stroke frequency continues to place a significant economic and health burden. There were 12.2 million incident strokes, 6.55 million deaths from stroke, and 143 million disability-adjusted life-years (DALYs) due to stroke, according to epidemiological data on the global disease burden in 2019 [2]. The risk of stroke rises progressively with age and may reach 69% in people over 65 years [3]. Therefore, identifying and managing risk factors for stroke is an effective and economical strategy for primary stroke prevention.

Remnant cholesterol (RC) is the amount of cholesterol found in intermediate-density lipoproteins, triglyceride-rich remnant lipoproteins, very low-density lipoproteins, and chylomicron remnants. Since RC carries most of the triglycerides in the plasma, RC concentration is strongly related to the triglyceride level, and a high triglyceride level is a sign of high RC [4]. In recent years, growing evidence has suggested that RC is the key factor in all-cause mortality and cardiovascular diseases (CVD) [5, 6]. However, the relationship between RC and stroke risk is still controversial. Some researchers have confirmed that RC is highly related to stroke risk [7, 8]. However, some evidence has indicated no significant correlation between RC and stroke [9,10,11,12]. In addition, almost no research has revealed the nonlinear relationship between RC and stroke, nor has subgroup analysis been used to evaluate the relationship between RC and stroke events.

The relationship between RC and stroke has sparked controversy in light of the studies above. Furthermore, when employing the Cox proportional hazards regression method to explore this connection, it becomes apparent that a nonlinear relationship could potentially influence the results. Therefore, we have formulated a hypothesis proposing the presence of nonlinearity between RC and stroke. In this context, the present study aimed to assess the influence of RC on the development of stroke among middle-aged and elderly Chinese adults by utilizing data from the China Health and Retirement Longitudinal Study (CHARLS).

Methods

Data source and study population

The CHARLS is a population-based, continuous longitudinal cohort study conducted nationally to assess social, health status, and economic factors [13]. The CHARLS provided the data for the current research. With 10257 homes and 17708 subjects participating in the baseline survey, the CHARLS sample was obtained from 450 communities in 150 districts, 28 provinces, and multi-stage probability sampling [13]. The sample was taken from the general retired population in China between June 2011 and March 2012 [13]. A longitudinal, face-to-face, computer-assisted personal interview was employed biennially to interact with the participants in the CHARLS [13]. Following the baseline survey from 2011 to 2012, survivors underwent three additional follow-up assessments from 2013 to 2014 (Wave 2), 2015 to 2016 (Wave 3), and 2017 to 2018 (Wave 4) [13]. The CHARLS website (http://charls.pku.edu.cn/en) has detailed information about the data [13]. Follow-up of fewer than two years, age < 45 years at baseline, lack of information on RC at baseline, history of stroke, lack of information on stroke at baseline, or treatment for stroke at baseline were exclusion criteria for the 17,708 patients enrolled in the study at the beginning. In the end, a total of 10067 subjects were included in the follow-up investigation (Fig. 1).

Fig. 1
figure 1

Study population

Full size image

Data collection

The CHARLS personnel at Peking University taught interviewers to use the computer-assisted personal interview method to conduct interviews in respondents' homes. Demographics, health conditions and functioning, chronic diseases diagnosed by a doctor, lifestyle, and health-related habits (drinking, physical activity, and smoking) were all included in the core CHARLS questionnaire [13]. In addition, to measure the health performance and functioning of the interviewees, the interviewers had the equipment to measure their blood pressure, height, and weight. Participants were invited to the township hospital or the nearby Centers for Disease Control and Prevention (CDC) office, where a skilled nurse took an 8 ml fasting blood sample. Complete blood count (CBC) testing was done between one and two hours after the sample was taken. While the CBC was done, the remaining blood was divided into plasma and blood cells and transported in a -20°C environment. For CDC analysis, all blood samples were shipped back to Beijing [13]. Diabetes mellitus was characterized by having fasting plasma glucose (FPG) levels ≥ 7.0 mmol/L, hemoglobin A1c (HbA1c) levels ≥ 6.5% [14], or a self-reported history of diabetes. Heart diseases were defined as myocardial infarction, coronary heart disease, congestive heart failure, or other heart diseases [13]. Hypertension was defined as blood pressure greater than 140/90 mmHg (average of 3 measurements) or a history of hypertension [13]. Physical activity was categorized as vigorous or moderate activity for more than 30 min at least once a week [13]. Participants who had previously smoked were defined as ever smokers, and those who still smoked were defined as current smokers [13]. Participants who reported that they had consumed alcoholic beverages in the past were defined as ever drinkers, and those who had consumed any alcoholic beverages within the last year were defined as current drinkers [13]. Participants with less than two years of follow-up (i.e., participants who did not receive any follow-up) were considered as lost to follow-up. Participants who were not followed up to Wave 4 (2017–2018) and did not reach the endpoint but were followed up for more than two years were defined as censorship.

Covariates assessments

Based on a combination of prior research and clinical expertise, covariates were chosen [13, 15, 16]. The subsequent factors were used as covariates: (i) categorical variables: diabetes mellitus, sex, hypertension, smoking status, drinking status, physical activity, and lipid therapy; (ii) continuous variables: age, serum creatinine (Scr), C-reactive protein (CRP), and serum cystatin C.

Assessment of remnant cholesterol level

The following is a description of the precise measurement process for RC: RC = total cholesterol (TC) (mmol/L)—low-density lipoprotein cholesterol (LDL-C)—high-density lipoprotein cholesterol (HDL-C) [17, 18].

Diagnosis of stroke

The outcome variable was incident stroke throughout the follow-up period. As noted before, the following standard query was used to collect information on incident stroke: "Have you been informed by a doctor that you have a stroke diagnosis?" or "Because of your stroke, are you presently receiving any of the following treatments: taking Western medicine, physical therapy, taking Chinese traditional medicine, acupuncture therapy, and occupational therapy" [13]. If the individual provided a positive response at follow-up, the respondent was classified as having a first stroke diagnosis, and the self-reported time was recorded as the onset of the stroke. The time of the event was determined by subtracting the time of the baseline survey from the time of stroke onset.

Missing data processing

It is difficult to completely avoid missing data in observational research, which is a common issue [19]. There were 8 (0.08%), 1502 (14.92%), 91 (0.90%), 54 (0.54%), 11 (0.11%), 5996 (59.56%), 169 (1.68%), 12 (0.12%), 13 (0.13%), 80 (0.79%), and 2464 (24.48%) individuals with missing data for gender, BMI, diabetes mellitus, hypertension, drinking status, physical activity, smoking status, FPG, Scr, HbA1c, and Cystatin C, respectively. Missing clinical variables were addressed via chained equations using multiple imputations for modeling purposes. Age, sex, BMI, diabetes mellitus, hypertension, drinking status, physical activity, smoking status, lipid therapy, FPG, Scr, HbA1c, CRP, triglyceride (TG), and Cystatin C were all incorporated in the imputation model, which employed linear regression and ten iterations. The assumption of missing at random was used in missing data analysis processes [19].

Statistical analysis

All participants were divided into four groups based on RC quartiles (Q1 ≤ 0.310 mmol/L; 0.310 mmol/L < Q2 ≤ 0.520 mmol/L; 0.520 mmol/L < Q3 ≤ 0.84 mmol/L; Q4 > 0.84 mmol/L). The continuous baseline data were expressed as the mean ± the standard deviation (SD) (normally distributed data) and medians (quartile) (nonnormally distributed data). The current study used the expression in numbers (percentages) for categorical data. Comparisons were made using either ANOVA (nonnormally distributed data), the χ2 test (categorical data), or the Kruskal–Wallis test (skewed data). Incidence rates were expressed in person-years and cumulative incidence.

Using Cox proportional hazards models, the current study calculated the hazard ratios (HR) and 95% confidence intervals (CI) for stroke events. In addition, three Cox proportional hazards models were performed. The current study referenced prior research and clinical expertise in selecting covariates. The inclusion of these covariates in the model led to a substantial change of 10% or more in the HR. In Model 1, no covariates were adjusted. In Model 2, BMI, gender, age, drinking status, physical activity, heart diseases, diabetes mellitus, hypertension, and smoking status were controlled. BMI, gender, age, drinking status, physical activity, heart diseases, diabetes mellitus, hypertension, smoking status, lipid therapy, CRP, Scr, and cystatin C were used as adjustment variables of Model 3. Controlling variables were adjusted based on clinical knowledge and published reports [13, 15, 16]. Based on the results of the collinearity screening, no covariates were excluded from the Cox proportional hazards regression models according to the screening results for collinearity (Table S1).

The current study performed numerous sensitivity analyses to evaluate the reliability of the results. The current study converted RC into a categorical variable depending on the quartiles of the RC. By determining P for the trend, the results of RC as a continuous variable were examined, and the possibility of nonlinearity between RC and incident stroke was investigated. Hypertension and obesity are strong risk factors for stroke [20, 21]. Given their potential to confound the association between RC and incident stroke, we adopted an exclusionary approach in our analysis. Specifically, individuals with BMI ≥ 24 kg/m2 and hypertension were systematically excluded from our study cohort. This methodological decision was undertaken with the primary aim of elucidating and corroborating the relationship between RC and stroke while ensuring the stability and robustness of our findings. Furthermore, to minimize potential sources of bias and enhance the internal validity of our investigation, we extended the exclusion criteria to encompass non-hypertensive individuals with BMI < 24 kg/m2. These exclusions were conducted to foster a more homogenous study population and minimize the influence of confounding variables, thereby allowing for a more precise examination of the relationship between RC and stroke.

Moreover, the current study tested the nonlinear relationship between RC and stroke risk using the Cox proportional hazards regression model with cubic spline functions and the smooth curve fitting. If nonlinearity was observed, the current study's initial step involved utilizing a recursive algorithm to calculate the inflection point. The algorithm was initiated arbitrarily, and filtering and smoothing techniques were employed to identify the inflection point. Subsequently, a two-piece Cox proportional hazards regression model was constructed on either side of the inflection point. The log-likelihood ratio was employed to determine the most appropriate model for elucidating the association between RC and the risk of stroke.

All the results were reported under the STROBE statement [22]. All analyses were conducted using R statistical software tools and Empower Stats. The threshold for statistical significance (two-sided) was established at P values less than 0.05.

Results

Participants’ characteristics

In the present study, there were 10,067 participants (4697 men and 5370 women) with an age range of 45 to 99 years and a mean age of 59.148 ± 9.348 years. Following a median follow-up of 7.0 years, 1180 (11.72%) individuals developed stroke.

Table 1 listed the characteristics of the study population. RC was classified into four groups based on the quartiles (Q1 ≤ 0.310 mmol/L; 0.310 mmol/L < Q2 ≤ 0.520 mmol/L; 0.520 mmol/L < Q3 ≤ 0.84 mmol/L; Q4 > 0.84 mmol/L). The current study showed that participants generally had higher levels of BMI, FPG, Scr, HbA1c, TG, and higher proportions of diabetes mellitus, hypertension, and lipid therapy in the Q4 group. In addition, participants in the Q1 group had lower levels of Cystatin C and higher rates in males.

Table 1 The baseline characteristics of participants
Full size table

The incidence rate of stroke

The cumulative incidence rate of stroke is shown in Table 2. Stroke incidence rates were 11.72% (11.09%-12.34%), 9.63% (8.48%-10.78%), 11.15% (9.92%-12.39%), 11.70% (10.45%-12.96%), and 14.39% (13.02%-15.76%) respectively for the general population, Q1 group, Q2 group, Q3 group, and Q4 group. The respective incidence rates were 19.21, 15.67, 18.22, 19.14, and 23.89 per 1,000 person-years for all individuals and the four RC groups.

Table 2 Incidence rate of incident stroke
Full size table

The risk factors for incident stroke

RC, age, BMI, female, current smokers, heart diseases, diabetes mellitus, hypertension, and lipid therapy were independent risk factors for stroke (Table 3). In addition, each unit increase in RC was linked to a 19.2% increase in the risk of stroke in Model 1 without adjusting for any variables (HR = 1.192, 95%CI: 1.108–1.282). The risk of stroke increased by 9.7% for every mmol/L rise in RC after adjusting for BMI, gender, age, drinking status, physical activity, heart diseases, diabetes mellitus, and hypertension in Model 2 (HR = 1.097, 95%CI: 1.014–1.188). Each unit of RC was associated with an 8.7% increase in stroke risk after adjusting for BMI, gender, age, drinking status, physical activity, heart diseases, diabetes mellitus, hypertension, lipid therapy, smoking status, CRP, Scr, and Cystatin C in Model 3 (HR = 1.087, 95%CI: 1.001–1.180). Additionally, the results revealed a significant association between the highest quartile (Q4) of RC and an increased risk of stroke when using the lowest quartile (Q1) as a reference (Model 1, Q4: HR = 1.520, 95%CI: 1.292–1.788) (Model 2, Q4: HR = 1.277, 95%CI: 1.080–1.510) (Model 3, HR = 1.261, 95%CI: 1.063–1.495) (Table 3).

Table 3 Relationship between RC and the incident stroke in different models
Full size table

Sensitivity analyses

The sensitivity analysis excluding individuals with BMI ≥ 24 kg/m2 (Table 4, Model 4) revealed a positive connection between RC and incident stroke after adjusting for confounding covariates (HR = 1.178, 95%CI: 1.028–1.349). RC remained positively associated with incident stroke after performing sensitivity analyses including non-hypertensive (Table 4, Model 5) and non-hypertensive subjects with BMI < 24 kg/m2 (Table 4, Model 6). After adjusting for confounding covariates, the HR was 1.134, 95%CI: 1.018–1.263 (Table 4, Model 5) and 1.281, 95%CI: 1.091–1.504 (Table 4, Model 6).

Table 4 Relationship between RC and stroke risk in different sensitivity analyses
Full size table

The analysis of the nonlinear relationship

Figure 2 presents the nonlinear relationship between RC and stroke risk. There was a non-linear correlation between RC and incident stroke after adjusting for confounding covariates (Table 5). The inflection point of RC was 1.78 mmol/L according to a two-piecewise Cox proportional hazards regression model (P for log-likelihood ratio test = 0.013). RC positively connected with the incident stroke when was RC < 1.78 mmol/L (HR:1.251, 95%CI: 1.089–1.437). In contrast, the connection between RC and incident stroke was not significant when RC ≥ 1.78 mmol/L (HR: 0.893, 95%CI: 0.736–1.084).

Fig. 2
figure 2

The nonlinear relationship between RC and incident stroke in Chinese individuals aged 45 years or older

Full size image
Table 5 The result of the two-piecewise Cox proportional hazards regression model
Full size table

Discussion

In this nationwide prospective cohort study of Chinese individuals aged 45 or older, we discovered a positive and nonlinear connection between RC and stroke risk. The connection between RC and stroke risk was a saturated effect curve with a point of inflection at 1.78 mmol/L. RC was associated with stroke occurrence after adjustment for confounders when RC < 1.78 mmol/L. In addition, we found that age, BMI, female, current smokers, heart diseases, diabetes mellitus, hypertension, and lipid therapy were independent risk factors for stroke. Clinically, risk mitigation strategies for stroke encompass the management of multiple factors, including control of risk factors such as elevated RC. Furthermore, a multifaceted approach involving the management of age, BMI, gender (specifically, female), tobacco use (current smokers), pre-existing heart diseases, diabetes mellitus, hypertension, and lipid therapy can synergistically contribute to a reduction in the overall risk of stroke. When applied in concert, these risk-modifying interventions may yield a more comprehensive and effective stroke prevention strategy within the clinical setting.

In the overall Chinese population, the incidence of stroke recently reached 2.47 per 1,000 person-years [23]. However, the incidence of stroke in the current study was 19.21 per 1,000 person-years, which is significantly higher than reported in previous research [23]. This disparity could be attributed to the predominant inclusion of individuals aged 45 years or older in the current research population. Therefore, it was reasonable to assume that the current study participants had a much higher incidence of stroke than the general population. Therefore, it was imperative to explore potential risk factors for stroke in adults aged 45 years and older.

The results of many studies in the past showed that RC is a high-risk factor for CVD. However, there is still debate and uncertainty surrounding the connection between RC and incident stroke. In a Korean longitudinal cohort study that included 1956452 patients with type 2 diabetes without atherosclerotic CVD, the highest RC quartile was independent of the risk of stroke compared with the lowest quartile risk factor (HR: 1. 281, 95%CI: 1.249–1.314) after adjustment for age, smoking status, sex, duration of diabetes, BMI, fibrate use, statin use, regular exercise, low income, alcohol drinking status, hypertension, and FPG [7]. In another cohort study involving 106937 subjects, elevated RC levels were related to a higher risk of ischemic stroke (HR: 1.8, 95%CI: 1.4–2.5) after adjustment for age, sex, low-density lipoprotein cholesterol, smoking status, cumulative smoking, systolic blood pressure, birth year, and atherosclerotic cardiovascular disease before baseline [8]. However, other studies reported no association between RC and stroke risk. In a United States cohort study of 9334 participants without CVD, the results of the study showed no association between RC in the high-level group and the incidence of new strokes compared to RC in the low-level group after adjusting for potential confounders (HR = 1.07; 95%CI:0.78–1.45) [11]. A prospective cohort study including 8782 subjects aged 45 or older from rural northeastern China demonstrated that RC was not related to stroke risk (HR:1.25, 95%CI: 0.94–1.66) after adjusting for potential confounders [10]. Elevated RC was not linked to an increased risk of stroke in patients with acute coronary syndromes or myocardial infarction in nonobstructive coronary arteries [9, 12]. The current study strengthened the argument that a high RC is positively associated with stroke risk in the existing literature. The possible reasons for these inconsistent findings are differences in the gender ratio, study populations, RC range, and adjustment factors of these studies. In addition, it was noteworthy that the results of linear regression analysis might be influenced by nonlinear connections, resulting in variations in the fitted linear relationship. In other words, the divergent findings from these studies could be attributed to a nonlinear association between RC and incident stroke.

After categorizing the RC into quartiles and using the first quartile (Q1) as the reference in the current study (Table 3, Model 3), the hazard ratios for the second (Q2), third (Q3), and fourth (Q4) quartiles were 1.146, 1.137 and 1.288, respectively. The findings from the analysis of RC as a categorical variable demonstrated a gradual increase in the risk of stroke from Q1 to Q4. This result is consistent with the results using RC as a continuous variable, indicating a consistent and stable relationship between RC and the risk of stroke.

Besides, we discovered the nonlinear connection between RC and incident stroke, performing a two-piecewise Cox proportional hazards regression model with a saturation effect. The inflection point of RC was 1.78 mmol/L after adjustment for confounders. The results indicated that for every unit increase in RC level when it was < 1.78 mmol/L, the probability of stroke elevated by 25.1% (HR:1.251, 95%CI: 1.089–1.437). However, each unit increase in RC level was not associated with incident stroke when RC was ≥ 1.78 mmol/L (HR: 0.893, 95%CI: 0.736–1.084). Based on the results above, it could be inferred that a decrease in RC was associated with a reduced risk of stroke when RC was below the inflection point. Conversely, when RC was above the inflection point, changes in RC did not significantly affect the risk of stroke. In other words, reducing RC was likely to lower the risk of stroke only when RC was below the inflection point. Therefore, from a clinical perspective, lowering RC below the inflection point might be an effective strategy for reducing the risk of stroke. Differences in the relationship between RC and stroke incidence on either side of the inflection point might arise from other factors affecting stroke risk. Table S2 displayed that compared with RC < 1.78 mmol/L, subjects with RC ≥ 1.78 mmol/L typically had greater FPG, BMI, TG, Scr, and HbA1c. However, all of these indicators were risk factors for stroke [24], which might weaken the effect of RC on stroke risk. On the other hand, when RC was lower than 1.78 mmol/L, these risk factors (FPG, BMI, TG, Scr, and HbA1c) for stroke were reduced, and their influence on stroke was lessened, and RC had a considerably enhanced effect on stroke.

By inducing atherosclerosis, RC might theoretically account for the mechanical link between increased RC and an elevated risk of stroke [17]. Previous studies demonstrated that RC, such as very-low-density lipoproteins (VLDL), triglyceride-rich lipoproteins (TGLs), and intermediate-density lipoproteins (IDL), could get into and lock the arterial intima [25,26,27,28], while large chylomicrons and the largest VLDL particles were unable to get into the arterial intima because of the size of these particles [29,30,31]. Because of this, small-size lipoprotein particles had a higher potential to cause an atherogenic reaction in the artery intima. These particles became stuck and found it difficult to return to the artery lumen by interacting with proteoglycans and other elements of the arterial intima, leading to cholesterol buildup [28]. For them to be picked up by scavenger receptors on the surface of macrophages after being trapped, they would first need to be changed. This would result in the creation of foam cells and the growth of atherosclerotic plaque [32]. Lipolysis products produced by RC particles, including oxidized free fatty acids, trigger the synthesis of cytokines, interleukins, and atherogenic adhesion molecules and might cause local inflammation in the arterial wall [33]. Therefore, RC's primary atherogenic action was mostly brought on by the size of its particles, which resulted in a lengthened residence period in the artery intima, enhanced penetration into the arterial wall, and increased sensitivity to oxidation.

Strengths

The current study presents the following strengths. First, this is the first study examining the connection between RC and incident stroke in subjects aged 45 or older. Second, the CHARLS project, a nationally representative cohort research with a high response rate, provided the data for this study. Third, the current study examined the nonlinear connection between RC and incident stroke. Previous studies explored the relationship between RC and stroke based on linear regression. And their results were inconsistent. Besides, a nonlinear relationship is a relationship between two variables in which change in one entity does not correspond with constant change in the other variable. This might mean the relationship between the two variables seems unpredictable or virtually absent. However, nonlinear entities can be related to each other in fairly predictable ways but are simply more complex than in a linear relationship because of the complexity of the relationship between RC and stroke. Therefore, the nonlinear relationship may also be closer to the relationship between RC and stroke risk. Fourth, residual confounding factors were minimized by using strict statistical adjustments. Fifth, the present study conducted sensitivity analyses to ensure the stability of the findings.

Limitations

The present investigation has some restrictions. First, Chinese adults over 45 were selected for the current study. Therefore, additional testing of these findings for younger populations and other ethnicities is required. Second, the current study was unable to differentiate between the various stroke types. Therefore, it is still unclear whether there is a connection between RC, hemorrhagic stroke, and ischemic stroke. Third, certain unmeasured confounders, such as the family history of stroke and diet, may have impacted the connection between RC and stroke risks. Fourth, the small proportion of the population (only 5%) with an RC greater than 1.78 mmol/L in this study might impact the precision and generalizability of the results. Fifth, stroke diagnosis in this study was solely based on self-report, without considering historical information and imaging findings. Despite the lack of CHARLS validation data specifically for self-reported stroke diagnosis, previous stroke epidemiological studies have reported sensitivity and specificity rates ranging from 78 to 96% and 96% to 98% [34,35,36] when using self-report. Future research aims to develop comprehensive studies incorporating historical information and imaging findings to enhance the accuracy of stroke diagnosis.

Conclusion

This current study revealed a positive and nonlinear connection between RC and stroke risk in a middle-aged and elderly Chinese population. A statistically significant positive correlation existed between stroke and RC levels lower than 1.78 mmol/L. Clinicians can use this finding as a guide to manage the RC level. Reducing the RC level below the inflection point makes sense from a therapy standpoint. When the RC level is below the inflection point, lowering it can considerably lower the risk of stroke.

Availability of data and materials

Data are available from http://www.isss.pku.edu.cn/cfps/. Follow the prompts to register as a user and download the data once it has been reviewed and approved.

Abbreviations

RC:

Remnant cholesterol

DALYs:

Disability-adjusted life-years

CVD:

Cardiovascular diseases

CHARLS:

China Health and Retirement Longitudinal Study

BMI:

Body mass index

FPG:

Fasting plasma glucose

TC:

Total cholesterol

TG:

Triglyceride

HDL-C:

High-density lipoprotein cholesterol

LDL-C:

Low-density lipid cholesterol

Non-HDL-C:

Non-high-density lipoprotein cholesterol

Scr:

Serum creatinine

HbA1c:

Glycosylated hemoglobin

CRP:

C-reactive protein

HR:

Hazard ratios

CI:

Confidence intervals

Ref:

Reference

sdLDL-C:

Small dense low-density lipoprotein-cholesterol

References

  1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 [published correction appears in Lancet. 2017 Jan 7;389(10064):e1]. Lancet. 2016;388(10053):1459–544. https://0-doi-org.brum.beds.ac.uk/10.1016/S0140-6736(16)31012-1.

  2. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. https://0-doi-org.brum.beds.ac.uk/10.1016/S1474-4422(21)00252-0.

  3. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, et al. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet. 2014;383(9913):245–54.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427–36.

    Article  CAS  PubMed  Google Scholar 

  5. Wadstrom BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44(16):1432–45.

    Article  PubMed  Google Scholar 

  6. Doi T, Langsted A, Nordestgaard BG. Elevated remnant cholesterol reclassifies risk of ischemic heart disease and myocardial infarction. J Am Coll Cardiol. 2022;79(24):2383–97.

    Article  CAS  PubMed  Google Scholar 

  7. Huh JH, Han KD, Cho YK, Roh E, Kang JG, Lee SJ, Ihm SH. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol. 2022;21(1):228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wadstrom BN, Wulff AB, Pedersen KM, Jensen GB, Nordestgaard BG. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study. Eur Heart J. 2022;43(34):3258–69.

    Article  CAS  PubMed  Google Scholar 

  9. Shao Q, Yang Z, Wang Y, Li Q, Han K, Liang J, Shen H, Liu X, Zhou Y, Ma X, et al. Elevated remnant cholesterol is associated with adverse cardiovascular outcomes in patients with acute coronary syndrome. J ATheroscler Thromb. 2022;29(12):1808–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chen Y, Li G, Guo X, Ouyang N, Li Z, Ye N, Yu S, Yang H, Sun Y. The effects of calculated remnant-like particle cholesterol on incident cardiovascular disease: insights from a general chinese population. J Clin Med. 2021;10(15):3388.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, et al. Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J Am Coll Cardiol. 2018;72(2):156–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gao S, Xu H, Ma W, Yuan J, Yu M. Remnant cholesterol predicts risk of cardiovascular events in patients with myocardial infarction with nonobstructive coronary arteries. J Am Heart Assoc. 2022;11(10):e24366.

    Article  Google Scholar 

  13. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.

    Article  PubMed  Google Scholar 

  14. Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–33.

    Google Scholar 

  15. Varbo A, Nordestgaard BG. Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population. Ann Neurol. 2019;85(4):550–9.

    Article  CAS  PubMed  Google Scholar 

  16. Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, Wu W, Chen Z, Wu S, Chen Y. Remnant cholesterol variability and incident ischemic stroke in the general population. Stroke. 2022;53(6):1934–41.

    Article  CAS  PubMed  Google Scholar 

  17. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–35.

    Article  CAS  PubMed  Google Scholar 

  18. Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, Zou Y, Ge J, Chen H. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010;9:52.

    Article  PubMed  PubMed Central  Google Scholar 

  19. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.

    Article  PubMed  Google Scholar 

  20. Pistoia F, Sacco S, Degan D, Tiseo C, Ornello R, Carolei A. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Car. 2016;23(1):9–18.

    Article  Google Scholar 

  21. Wang X, Huang Y, Chen Y, Yang T, Su W, Chen X, Yan F, Han L, Ma Y. The relationship between body mass index and stroke: a systemic review and meta-analysis. J Neurol. 2022;269(12):6279–89.

    Article  PubMed  Google Scholar 

  22. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.

    Article  Google Scholar 

  23. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y, Wang Y, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–71.

    Article  PubMed  Google Scholar 

  24. Cui X, Wei W, Qin X, Hou F, Zhu J, Li W. Comparison of routine hematological indicators of liver and kidney function, blood count and lipid profile in healthy people and stroke patients. PeerJ. 2020;8:e8545.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Balling M, Langsted A, Afzal S, Varbo A, Davey SG, Nordestgaard BG. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals. Atherosclerosis. 2019;286:97–104.

    Article  CAS  PubMed  Google Scholar 

  26. Nordestgaard BG, Tybjaerg-Hansen A, Lewis B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler Thromb. 1992;12(1):6–18.

    Article  CAS  PubMed  Google Scholar 

  27. Shaikh M, Wootton R, Nordestgaard BG, Baskerville P, Lumley JS, La Ville AE, Quiney J, Lewis B. Quantitative studies of transfer in vivo of low density, Sf 12–60, and Sf 60–400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb. 1991;11(3):569–77.

    Article  CAS  PubMed  Google Scholar 

  28. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547–63.

    Article  CAS  PubMed  Google Scholar 

  29. Nordestgaard BG, Stender S, Kjeldsen K. Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall. Arteriosclerosis. 1988;8(4):421–8.

    Article  CAS  PubMed  Google Scholar 

  30. Nordestgaard BG, Zilversmit DB. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res. 1988;29(11):1491–500.

    Article  CAS  PubMed  Google Scholar 

  31. Boren J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473–83.

    Article  CAS  PubMed  Google Scholar 

  32. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537–57.

    Article  PubMed  Google Scholar 

  33. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide SI, Nakamura SI, Yasue H. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation. 2000;102(6):670–6.

    Article  CAS  PubMed  Google Scholar 

  34. Engstad T, Bonaa KH, Viitanen M. Validity of self-reported stroke : the tromso study. Stroke. 2000;31(7):1602–7.

    Article  CAS  PubMed  Google Scholar 

  35. O’Mahony PG, Dobson R, Rodgers H, James OF, Thomson RG. Validation of a population screening questionnaire to assess prevalence of stroke. Stroke. 1995;26(8):1334–7.

    Article  CAS  PubMed  Google Scholar 

  36. Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc. 2004;52(1):123–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The data and interpretative methods for the current study were obtained from the China Health and Retirement Longitudinal Study. We are grateful to the CHARLS study team and those participants who participated in the CHARLS study.

Funding

This study was supported by the Natural Science Funding of China (No.82272598, No.81901470).

Author information

Author notes

  1. Yuanqing Wang, Fubing Zha and Yong Han have contributed equally to this work.

Authors and Affiliations

  1. Department of Functional Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, 518035, Guangdong, China

    Yuanqing Wang & Xiaodong Cai

  2. Department of Rehabilitation, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, 518035, Guangdong, China

    Fubing Zha, Miaoling Chen & Changchun Cao

  3. Department of Emergency, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, 518035, Guangdong, China

    Yong Han

  4. Department of Rehabilitation, Shenzhen Dapeng New District Nan’ao People’s Hospital, No. 6, Renmin Road, Dapeng New District, Shenzhen, 518000, Guangdong Province, China

    Ying Cai, Cui Yang, Changchun Cao & Jiao Luo

  5. Department of Nephrology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, No.3002, Sungang West Road, Futian District, Shenzhen, 518000, Guangdong Province, China

    Haofei Hu

Authors
  1. Yuanqing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fubing Zha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miaoling Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaodong Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Haofei Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Changchun Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jiao Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Yuanqing Wang, Fubing Zha, and Yong Han conceived the research and drafted the manuscript. Ying Cai, Miaoling Chen, Cui Yang, and Xiaodong Cai performed the statistical analysis. Haofei Hu, Changchun Cao, and Jiao Luo were the guarantors of this work and thus had full access to all data in the study and were responsible for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Haofei Hu, Changchun Cao or Jiao Luo.

Ethics declarations

Ethics approval and consent to participate

The Biomedical Ethics Review Committee of Peking University approved this study, which was carried out ethically and in compliance with the Helsinki Declaration. Additionally, written informed consent has been obtained from all participants (IRB00001052–11015).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. The results of the collinearity screening. Table S2. The Baseline Characteristics of participants based on inflection point for RC.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Zha, F., Han, Y. et al. Nonlinear connection between remnant cholesterol and stroke risk: evidence from the China health and retirement longitudinal study. Lipids Health Dis 22, 181 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12944-023-01943-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12944-023-01943-8

Keywords

Lipids in Health and Disease

ISSN: 1476-511X